TWST: Please give me a little bit of a background on Cove Street Capital. How long has it been around and how big is it?
Mr. Claremon: We launched July 1, 2011. Our Founder is Jeffrey Bronchick who was the Chief Investment O

Ben Claremon joined Cove Street Capital, LLC, in July 2011 as a Research Analyst after graduating with an MBA from the UCLA Anderson School of Management. Previously, he worked as an Equity Analyst on the long and the short side for hedge funds, Blue Ram Capital and Right Wall Capital in New York, and interned at West Coast Asset Management in Santa Barbara, Calif... More
Eugene Robin, CFA, joined Cove Street Capital in July 2011 as a Research Analyst from Proton Capital, a family office, where he developed investment ideas in public and private markets. He was also responsible for vetting and monitoring investments in the alternative asset space. Mr. Robin holds an MBA from the UCLA Anderson School of Management, a computer science degree from UC San Diego and received his CFA charter in 2011... More
Published April 26, 2014 in Biotechnology and Pharmaceuticals
Buy ($75)"We’re a faith-based and socially responsible investing firm"
Published May 16, 2013 in Investing in Health Care
Buy ($75)"The fund is about $40 million in assets"
Published May 16, 2013 in Investing in Health Care
Buy ($75)Published May 14, 2013 in High-Yield Equity Securities
Buy ($75)Published May 16, 2013
Published May 10, 2013
Published May 10, 2013